Alamar Biosciences ALMR Balance Sheet Statement
| Q1 '26 | Q4 '25 | ||
|---|---|---|---|
| $64.59M— | $30M— | ||
| $4.91M— | $4.91M— | ||
| $19.52M+3,563% | $12.75M— | ||
| $39.93M+1,594% | $38.48M— | ||
| $17.43M+9,227% | $13.47M— | ||
| $141.47M— | $94.71M— | ||
| $10.47M— | $10.5M— | ||
| $186.45M— | $139.99M— | ||
| $5.64M+875% | $5.87M— | ||
| $1.6M— | $2.1M— | ||
| $24.05M— | $23.73M— | ||
| $28.98M— | $29.56M— | ||
| $30.58M— | —— | ||
| $1.2M— | $599K— | ||
| $129.53M— | $63.95M— | ||
| $12.11M— | $9.89M— | ||
| -$190.1M— | -$168.78M— | ||
| -$80K— | -$72K— | ||
| -$178.07M— | -$158.95M— | ||
| $186.45M— | $139.99M— | ||
| $1.84M— | $1.99M— | ||
| $2.09M— | $1.76M— | ||
| $25.67M— | $26.13M— | ||
| $1.84M— | $1.99M— | ||
| $25.67M— | $26.13M— | ||
| $2.09M— | $1.76M— | ||
| $25.67M— | $26.13M— | ||
| $1.84M— | $1.99M— | ||
| $16.81M— | $15.76M— | ||
| $30.58M— | $31.66M— | ||
| $1K— | $1K— | ||
| $65.09M— | —— | ||
| $9.88M— | $9.81M— | ||
| $331K— | $247K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Alamar Biosciences 's total assets?
- Alamar Biosciences (ALMR) holds $186.5M in total assets.
- How much debt does Alamar Biosciences have?
- Alamar Biosciences carries $30.6M in total debt against -$178.1M of shareholders' equity, a debt-to-equity ratio of -0.17.
- How much cash does Alamar Biosciences have?
- Alamar Biosciences holds $64.6M in cash and equivalents.
- Can Alamar Biosciences cover its short-term obligations?
- Its current ratio is 5.88 — current assets exceed current liabilities.
- Where does Alamar Biosciences 's balance sheet data come from?
- Every line is extracted from Alamar Biosciences 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.